Nike has seen its share value fall for four consecutive years, erasing roughly 57% of peak market capitalization from late 2021. Once celebrated for delivering annualized returns well above 20% over decades, the company now faces skepticism as its direct-to-consumer pivot and brand momentum have stalled. Investors who bought at the 2021 highs are sitting on substantial unrealized losses, and even dividend increases—Nike has raised its payout for 23 straight years—have done little to stem outflows from mutual funds and retail accounts.

In the wake of pandemic lockdowns, Nike overinvested in digital channels at the expense of wholesale partnerships and mall-based stores. The shift was meant to boost margins by cutting out intermediaries, but instead ceded shelf space to competitors. While North American footwear sales have rebounded—up approximately 9% year-over-year to $3.54 billion in Q2 fiscal 2026—inventory levels remain elevated and full-price sell-through rates have deteriorated, prompting management to announce plans to scale back digital marketing spend and renegotiate partner contracts.

Once a cornerstone of Nike’s growth thesis, Greater China revenues have plummeted for six straight quarters, falling 20% year-over-year in Q2. The decline reflects a shift in consumer preferences toward domestic ‘guochao’ brands and growing sensitivity to paying premium prices for foreign labels produced locally. Approximately 18% of Nike’s global footwear output is still manufactured in China, but technology leakage and high-quality counterfeits have diluted the brand’s differentiation, forcing the company to rely on aggressive promotions to maintain market share.

Top executives and board members disclosed open-market purchases totaling over $4 million in late December, including CEO Elliott Hill’s acquisition of 16,388 shares and director Tim Cook’s purchase of roughly 50,000 shares. While such insider activity is often viewed as a vote of confidence, Nike’s forward price-to-earnings multiple stands near 38—far above the S&P 500 average of 22. Analysts warn that until the company demonstrates sustained market share gains in China and consistent full-price sell-through in North America, the premium valuation may be unjustified.